Other
Gingival Inflammation
1
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Gingival Inflammation is an early-stage landscape with 1 program across 1 company. The most active players are Izun Pharma Ltd. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Approved
No programs
Analysis
Trial Status
8
clinical trials
Completed5 · 63%
Unknown status1 · 13%
Suspended1 · 13%
Not yet recruiting1 · 13%
Clinical Trials
Trial Activity
8 trials
Gels to Treat and Prevent Gingival Inflammation Around Dental Implants
Completed·—·Phase 1·NCT06915623·8 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)